Events
BACKGROUND Femasys Inc. has been a LifeSci client since July 2021. As part of a strategy to raise the Company’s visibility amongst global investors, LifeSci organized and hosted an in-person High-Net-Worth and family-office investor event for Femasys in New York City. The event created a great opportunity for Femasys to showcase its first-in-class technologies in…
Read More
enVVeno Medical Corporation became a LifeSci Advisors client in 2021. The teams collaborated to develop and execute a robust, best-in-class investor relations program to engage the investment community and showcase enVVenos developments. PROCESS This event featured a live virtual presentation featuring two principal investigators from the ongoing VenoValve U.S. pivotal trial: Dr. David Dexter, Sentara…
Read More
Inspire Medical became a LifeSci Advisors client pre-IPO. The teams collaborated to develop and execute a robust, best-in-class investor relations program to engage the investment community The Process A successful strategically timed KOL event before going live on the IPO was well attended by investors and sell-side analysts, attracting potential investors new to the story…
Read More
BioInvent became a LifeSci Advisors client in 2016. The teams collaborated to develop and execute a robust, best-in-class investor relations program to engage the investment community. PROCESS The event featured a presentation by renowned lymphoma expert Mats Jerkeman MD, Lund University, who discussed the current treatment landscape, and unmet medical need for patients with relapsed or…
Read More